Patents by Inventor Edward WAKELAND

Edward WAKELAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
    Publication number: 20240077496
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Application
    Filed: June 21, 2023
    Publication date: March 7, 2024
    Applicant: The Board of Regents of The University of Texas System
    Inventors: David E. Gerber, Edward Wakeland, Quan Li, Saad Khan, Jason Y. Park, Xin Luo, Yang Xie
  • Prediction and treatment of immunotherapeutic toxicity
    Patent number: 11747345
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Grant
    Filed: February 19, 2018
    Date of Patent: September 5, 2023
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: David E. Gerber, Edward Wakeland, Quan Li, Saad Khan, Jason Y. Park, Xin Luo, Yang Xie
  • PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
    Publication number: 20210263045
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy—induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Application
    Filed: April 8, 2019
    Publication date: August 26, 2021
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Edward WAKELAND, David E. GERBER, Quan LI, Shaheen KHAN, Saad KHAN, Yang XIE, Jason Y. Park, Farjana FATTAH, Xin LUO
  • PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
    Publication number: 20200284803
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Application
    Filed: February 19, 2018
    Publication date: September 10, 2020
    Applicant: The Board of Regents of the University of Texas System
    Inventors: David E. GERBER, Edward WAKELAND, Quan LI, Saad KHAN, Jason Y. PARK, Xin LUO, Yang XIE